MISSION

iQ Bio Investments focuses on investing in early stage life sciences companies with disruptive and breakthrough technologies and discoveries that can potentially address huge unmet medical needs for Oncology & Immunology that enhance quality of life.

We leverage our experience and in-depth understanding of the biopharma industry, our long-term relationships with leading investors, and our world-class scientific advisory network to fund seed & early-stage companies.

TEAM

 

Christopher Ng

MANAGING DIRECTOR

MANAGING DIRECTOR

10+ years in Process Operations
- iQ Biosciences
- US Dept of Defense
- Wind River Systems
Click Me!

JAMES LEE

DIRECTOR

DIRECTOR

17+ years in Information Technology Consulting
- iQ Biosciences
- Accenture
Click Me!
 

PORTFOLIO

 

BioGraph 55 focuses on target discovery and drug development in immuno-oncology by leveraging a proprietary and validated spatial-mapping technology platform that collects biological information from cellular interactions in their native environment and integrates this information with other data to identify novel drug targets.

Learn More
 

CONTACT US